1. Bozak, RIchard; Knittel, J.; Hicks, Ronald. "Convenient synthesis of a lactone, gamma-butyrolactone". Journal of chemical education. 1998. 75(1). 84.

2. "chemical prices". catalogs: Sigma-Aldrich, Lancaster, ICN. 1995-1998.

3. Snead, O.; Bearden, Larry. "Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate". Neurology. 1980. 30. 832-838.

4. Mamelak, Mortimer; Escriu, Joseph; Stokan, Olga. "The effects of Gamma-hydroxybutyrate on sleep". Biological Psychiatry. 1977. 12(2). 273-288.

5. Snead, O.. "Gamma Hydroxybutyrate in the monkey - I: electroencephalographic, behavioral, and pharmacokinetic studies". Neurology. 1978. 28. 636-642.

6. Snead, O.. "Gamma Hydroxybutyrate in the monkey - II: effects of chronic oral anticonvulsant drugs". Neurology. 1978. 28. 643-648.

7. Takahara, J; Yunoki, S; Yakushiji, W; Yamauchi, J; Yamane, J; Ofuji, T. "Stimulatory effects of gamma hydroxybutyric acid on growth hormone and prolactin release in humans". Journal of CLINical ENDOCRINAL METABolism. 1977. 44. 1004.

8. Snead, O.. "Gamma Hydroxybutyrate in the monkey - III: effect of intravenous anticonvulsant drugs". Neurology. 1978. 28. 1173-1178.

9. Luby, Stephen.; Jones, Jeffrey.; Zalewski, Alan. "GHB use in South Carolina". American Journal of Public Health. 1992. 82. 128. RA 421 A 51.

10. Ferrara, SD. Zotti, S. Tedeschi, L. Frison, G. Palatini, P. et al.. "Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent. . .". British Journal of Clinical Pharmacology. 1992. 34. 231-235. R 31 B 93. .

11. Snead, O.. "Gamma Hydroxybutyrate in the monkey - 4: Dopaminergic mechanisms". Neurology. 1978. 28. 1179-1182.

12. Colombo, Giancarlo; Agabio, Roberta. "Oral self-administration of gamma-hydroxybutyric acid in the rat". European Journal of Pharmacology. 1995. 285(1). 103-107. RT 120 E 4.

13. FDA . "Injuries, deaths linked again to GHB abuse". FDA Consumer. 1997. 31. 2.

14. Marwick, Charles. "ComaComa (ou comatose) é o estado no qual uma pessoa perde completa ou parcialmente a consciência, não tem reações nervosas, ou reage pouco ou nada a estímulos externos.-inducing drug GHB may be reclassified. ". JAMA. 1997. 277. 1505. R 152 K56.

15. Snead, O.; Yu, Robert; Huttenlocher, Peter. "Gamma hydroxybutyrate: Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects". Neurology. 1976. 26. 51-56.

16. Armstrong, Robert. "When drugs are used for rape". Journal of Emergency Nursing. 1997. 23(4). 378-381. RT 120 E 4.

17. Mendels, J.; Hawkins, D.R.. "Effect of bytyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycles in man". electroencephalography and clinical neurophysiology. 1967. 22. 558-562.

18. Ross, Tracy McIntyre. "Gamma Hydroxybutyrate Overdose(em inglês.: overdose)O uso de qualquer droga em quantidade suficiente para provocar efeitos indesejáveis físicos e mentais mais ou menos imediatos. A superdosagem deliberada é um meio comum de suicídio ou de tentativa de suicídio. Em números absolutos, as superdosagens de drogas lícitas são geralmente mais comuns do que as de drogas ilícitas. A superdose pode provocar efeitos transitórios, duradouros ou a morte; a dose letal de uma droga em particular varia com o indivíduo e com as circunstâncias.Veja também:intoxicação; envenenamento por álcool ou droga: Two Cases Illustrate the Unique Aspects of". Journal of Emergency Nursing. 1995. 21(5). 374-76. RT 120 E 4.

19. Arena, C.; Fung, Ho-leung. "Absorption of sodium-gammahydroxybutyrate and its prodrug, gamma-butyrolactone: Relationship between in vitro transport and in vivo absorption". Journal of pharmaceutical sciences. 1980. 69(3). 356-358.

20. Cauter, Eva; Plat, Laurence; Scharf, Martin; Leproult, Rachel; et al.. "Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men". Journal of clinical investigation. 1997. 100(3). 745-753.

21. Rosen MI. Pearsall HR. Woods SW. Kosten TR.. "Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients". Journal of Substance Abuse Treatment. 1997. 14(2). 149-54. RC 563 J687.

22. Bismuth C. Dally S. Borron SW. "Chemical submission: GHB, benzodiazepines, and other knockout drops". Journal of Toxicology - Clinical Toxicology. 1997. 35(6). 595. RA 1190 C 56.

23. Saum, Christine; Inciardi, James A.. "Rohypnol misuse in the United States". Substance use and misuse. 1997. 32(6). 723-731.

24. Roth, R.H.; Giarman, N.J.. "Evidence that central nervous system depression by 1,4-butanediol is mediated through a metabolite, gamma-hydroxybutyrate". Biomedical Pharmacology. 1968. 17. 735-739.

25. Winters, Wallace; Mori, Kenjiro; Spooner, Charles; Nauer, Robert. "The neurophysiology of anaesthesia". Anesthesiology. 1967. 28(1). 65-80.

26. James, Charose. "Another Case of Gamma Hydroxybutyrate (Ghb) OverdoseVeja superdose.". Journal of Emergency Nursing. 1996. 22(2). 97. RT 120 E 4.

27. Crosby, Gregory; Ito, Masanori; Kaufman, Elaine; Nelson, Thomas; Sokoloff, Louis. "Naloxone pretreatment alters the local cerebral metabolic effect of gamma-hydroxybutyrate in rats". Brain Research. 1983. 275. 194-197.

28. . "Helping alcohol misusers abstain". Nursing Standard. 1998. 12(18). 25..

29. Hechler, Vivane; Peter, Pascale; Gobaille, Serge; et al.. "Gamma-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities". Journal of pharmacology and experimental theraputics. 1993. 264(3). 1406-1414.

30. Boyd, April; Sherman, Igor; Sabil, Fred. "The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster". Gastroenterology. 1990. 99. 860-862.

31. Hechler, Viviane; Ratomponirina; Maitre, Michael. "Gamma-hydroxybutyrate conversion into GABA induces displacement of GABA-b binding that is blocked by Valproate and Ethosuximids". Journal of pharmacology and experimental theraputics. 1997. 281(2). 753-760.

32. Devoto, Paola; Colombo, Giancarlo; et al.. "Naloxone antagonizes ethanol- but not gamma-hydroxybutyrate-induced sleep in mice". European journal of pharmacology. 1994. 252. 321-324.

33. Galloway, Grantt; Frederick, S L; Gonzales, Marco; et al . "Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence". Addiction . 1997. 92(1). 98-96.

34. Dyer, Jo Ellen. "Gamma-Hydroxybutyrate: A health food product producing coma and seizurelike activity". American Journal of Emergency Medicine . 1991. 9. 321-4.

35. Guidotti, A and Ballotti, Paola . "Relationship between pharmacological effect and blood and brain levels of Gamma-hydroxybutyrate and gamma-butyrolactone". Biochemical pharmacology . 1970. 19. 883-94.

36. Hutchins, D A; Rayevsky, K S, and Sharman, D F . "The effect of sodium Gamma-hydroxybutyrate on the metabolism of dopamine in the brain". British Journal of pharmacology . 1972. 46. 409-15.

37. Thomas, Gareth; Bonner, Stephen; Gascogine, Alastair. "Coma induced by abuse of gamma-hydroxybuterate (GBH or liquid ecstasy): a case report". British Medical Journal. 1997. 314. 35.

38. Farley, Dixey. "Prom night incident leads to GHB prosecutions". FDA Consumer . 1991. 25(5). 34.

39. Laborit H . "Sodium 4-Hydroxybutyrate". INTernational Journal NEUROPHARMACOLOGY. 1964. 3. 433-52.

40. FDA . "Warning about GHB". JAMA . 1991. 265(14). 1802. R 152 K56.

41. Swygert, Lesile; Maes, Edmond; Sewell, Leann; et al . "Eosinophilia-Myalgia syndrome - results of national surveillance". JAMA . 1990. 264(3). 1698. R 152 K56.

42. Centers for Disease Control and Prevention . "Gamma Hydroxy Buterate Use -- New York and Texas, 1995-1996". Morbidity and Mortality Weekly Report . 1997. 46(13). .

43. Miguez, I; Aldegunde, M; Duran, R; and Veira, JA . "Effect of low-dose Gamma-hydroxybutyrate on serotonin, noradrenaline, and dopamine concentrations in rat brain areas". Neurochemical Research . 1988. 13. 531-33.

44. Marcus, R J; Winters, W D; and Hultin, E . "4-substituted butyrates in the rat". Neuropharmacology . 1976. . 29-38.

45. Mamelak, Mortimer. "Gamma-hydroxybutyrate: and endogenous regulator of energy metabolism". Neuroscience and Biobehavioral Reviews . 1989. 13. 187-98.

46. McCabe, E R; Layne, E C; Sayler, D F; et al . "Synergy of ethanol and a natural soporific - Gamma-hydroxybutyrate". Science . 1971. 171. 404-6.

47. Lapierre, Odile; Lamarre, Monique; Montplaisir, Jaques; and Lapierre, Guy . "The effect of Gamma-hydroxybutyrate: a double-blind study of normal subjects". Sleep Research . 1988. 17. 99.

48. Einspruch, Burton C and Clark, S Michael . "Near Fatality from health food store sleeping potion". Texas Medicine . 1992. 88(12). 10.

49. Massey, Shish . "Facing the Facts". The Daily Texan . 35853. 97(100). .

50. Gallimberti L, Gentile N, Cibin M, Fadda F, Canton G, Ferri M, Ferrara SD and Gessa GL . "Gamma hydroxybutyric acid for treatment of alcohol withdrawal syndrome". THE LANCET. 1989. 36068. 787-9.

51. USP . "Sodium Oxybate (Soduim Gamma-hydroxybutyrate)". USP DI - Drug information for the health care professional . 1990. V-IB. LOCation RM145 U183.

52. Chin, Ming-yan, Kreutzer RA and Dyer JE . "Acute poisoning from gamma-hydroxybutyrate in California". Western Journal of Medicine (United States). 1992. 156(4). 380-384.

53. Schmidt, Catherine; Gobaille, Serge; Hechler, Viviane; et al.. "Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist". European Journal of Pharmacology. 1991. 203. 393-397.

54. Centers for Disease Control and Prevention . "Multistate outbreaks of poisonings associated with illicit use of Gamma-hydroxybutyrate". Morbidity and Mortality Weekly Report . . 39(47). 861-2.

55. Snead, O.. "Noradrenergic mechanisms in gamma-hydroxybutyrate-induced seizure activity". European Journal of Pharmacology. 1987. 136. 103-108.

56. Louagie, Henk; Verstraete, Alain; De Soete, Christopher; Baetens, Dimitri; Calle, Paul. "A sudden awakening from a near coma after combined intake of Gamma-hydroxybutyrate (GHB) and ethanol". Journal of Toxicology - Clinical Toxicology. 1997. 36(6). 591-594.

57. Segal, Marian; Weisheit, Ruth; Williams, Rebecca. "L-tryptophan recall expanded". FDA consumer. 6/1991. . 38-39.

58. FDA. "Illness with GHB use". FDA consumer. 3/1991. 5.

59. Hechler, Viviane; Gobaille; Maitre, Michel. "Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autpradiography". Brain Research. 1992. 572. 345-348.

60. Trebay, Guy. "The Model Drug: GHB puts a happy face on fashion week". Village Voice. 1997. 41(5). 29-31.

61. Gorman, Christine. "Liquid X". Time. 1996. 9/30. 64.

62. Rogers, Patrick; Katel, Peter. "The new view from on high". Newsweek. 1993. 12/6. 62.

63. Roufs, James. "Review of L-tryptophan and eosinophilia-myalgia syndrome". Journal of the American Dietetic association. 1992. 2(7). 844-50.

64. Tunnicliff. "Sites of action of Gamma-hydroxybutyrate (GHB) a neuroactive drug with abuse potential". Journal of Toxicology - Clinical Toxicology. 1997. 35(6). 581-590.

65. Ledray, Linda. "Date Rape Drug Alert". Journal of Emergency Nursing. 1996. 22(1). 80.

66. Wagner, K.R.; Elmore, J.G.; Horwitz, R.I.. "Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome". Journal of rheumatology. 1996. 23(12). 2079-2085..

67. Simat, T.; van Wickern, B.; Eulitz, K.; Steinhart, E.H.. "Contaminants in biotechnologically manufactured L-tryptophan". Journal of Chromatography B: Biomedical applications. 1996. 685(1). 41-51..

68. Dillmann, Joseph. "GHB-A drug you should know". Nursing. 1997. september. 32cc15-16.

69. Sanguineti, Vincenzo; Angelo, Anita; Frank, Marion. "GHB: A home brew". American Journal of drug and alcohol abuse. 1997. 23(4). 637-642.

70. Friedman, Joseph; Westlake, Robert; Furman, Martin. ""Grevious Bodily Harm:" Gamma hydroxybutyrate abuse leading to a Wernike-Korsakoff syndrome". Neurology. 1996. 46. 469-471.

71. Tunnicliff, G.. "Significance of gamma-hydroxybutyric acid in the brain". General Pharmacy. 1992. 23(6). 1027-1034.

72. Vayer, Philippe; Mandel, Paul; Maitre, Michel. "Minireview: Gamma-hydroxybutyrate, a possible neurotransmitter". Life Sciences. 1987. 41. 1547-1557.

73. Green, A. RIchard; Goodwin, Guy. "Ecstacy and neurodegeneration". British Medical Journal. 6/15/1996. 312. 1493-4.

74. Mandel, Paul; Maitre, Michel; Vayer, Philippe; Hechler, Viviane. "Function of Gamma-hydroxybutyrate - a putative neurotransmitter". Biochemical society transactions. 1986. 15. 215-217.

75. Addolorato, G. et al.. "Maintaining abstenence from alcohol with gammahydroxybutyric acid". Lancet. 1998. 351(9095). 38.

76. Inaba, DS.. "Current trends in drug abuse". ASHP Midyear Clinical Meeting. 35034. 30. PI-137. . CD-ROM.

77. Yamada, Y; Yamamoto, J.; Fujiki, A. et al.. "Effect of gamma-butyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycle in man". electroencephalog. clin. neurophysiol.. . 22. 558.

78. Hoes, M.; Vree, T.; Guelen, P.. "gammahydroxybutyric acid as hypnotic: clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as a hypnotic in man". L'encephale. 1980. 69. 93-99.

79. Maitre, Michel; Ratomponirina, Charline; Gobaille, Serge; et al.. "Displacement of [3H]gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics". European Journal of Pharmacology. 1994. 256. 211-214.

80. Roth, Robert; Giarman; Nicholas. "Gamma-butyrolactone and gamma-hydroxybutyric acid - I : distribution and metabolism". Biochemical Pharmacology. 1966. 15. 1333-1348.

81. Diana, Marco; Mereu, Gianpaolo; Mura, Anna; et al.. "Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats". Brain Research. 1991. 566. 208-211.

82. Cash, Christopher. "Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful theraputic agent". Neuroscience and biobehavioral reviews. 1994. 18(2). 291-303.

83. US gov.. "Availability for public disclosure of data and information in an IND". FDA website. . Title 21 CFR sec. 312.130. .

84. Gmaster. "GHB kit instructions". http://www.en.com/users/web1/gmaster/.

85. Stell, IM. Ryan, JM.. "Ecstasy and neurodegeneration: gamma-hydroxybutyrate is a new recreational drug that may lead to loss of consciousness". British Medical Journal. 1996. 313. 424. R 31 B 93.

86. Krsiak, M.; Novakova, D.; Paclt, I.; Ostrovskaya, R.U.. "Effectrs of sodium-hydroxybutyrate on behavior of mice after prolonged isolation". Bulletin of experimental biology and medicine. 1974. 77(3). 288-291.

87. Henkel, John. "Gym owner jailed for GHB sales". FDA consumer. 4/1997. . 34-5.

88. Entholzner E. Mielke L. Pichlmeier R. Weber F. Schneck H. "EEG changes during sedation with gamma-hydroxybutyric acid. [German]". Anaesthesist. 1995. 44(5). 345-50.

89. Liboni W. Cipolla U. Oddenino E. Pasquero G.. "Out-patient treatment with gamma-hydroxybutyric acid in alcohol addiction". Gazzetta Medica Italiana. 1995. 154(1). 9-17.

90. Artru AA, Steen PA and Michenfelder JD . "Gamma-Hydroxybutyrate: Cerebral metabolic, vascular, and protective effects". Journal of NEUROCHEMISTRy. 1980. 35(5). 1114-1119. . no.

91. Vickers MD . "Gamma-hydroxybutyric Acid". INTernational ANAESTHESIA CLINIC . 1969. 7. 75-89. . no.

92. Kleimenova NN, Ostrovskaya RU and Arefolov VA . "Effect of sodium hydroxybutyrate on the ultrastructure of the cross-striated muscle tissue myocytes during physical exercise". Bulletin of experimental biology and medicine. 1979. 88(9). 358-61. R850 B8.

93. Winters, W.D.. Psychotomimetic Drugs. Raven Press, NY. 1970. . 193-234. .

94. Laborit H . "Correlations between protein and serotonin synthesis during various activities of the central nervous system (slow and desynchronized sleep, learning and memory, sexualA saúde sexual refere-se às áreas da medicina envolvidas com a reprodução humana e comportamento sexual, as doenças sexualmente transmissíveis, os métodos contraceptivos, anticoncepcionais, entre outros. activity, morphine tolerance, aggressiveness, and pharmacological action of sodium ga. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY. 1972. 3(1).

95. . "". Autoimmunity. . 25(1). 33.

96. . "". Missouri Medicine. 1995. 92. 354-357.

97. . "". Behavioral Pharmacology. . 6(supp. 1). 84.

98. . "". Veterenary and human toxicology. 1997. 39(4). 234.

99. . "". Muscle and fitness. 1997. 58(11). 156.

100. . "". Druglink. 1994. 9(5).

101. Ashworth, LE.. "When patients ask what is GHB". Southern Journal of Health-System Pharmacy. 1997. 2(1). 18-20 .

102. erra G. Caccavari R. Fontanesi B. Affini G F. Maestri D. Avanzini P.. "Naloxone and metergoline effects on growth hormone response to Gamma-hydroxybutyrate". International Clinical Psychopharmacology. 1995. 10(4). 245-250 .

103. Fadda F, Colombo G, Mosca E and Gessa GL . "Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats". ALCOHOL AND ALCOHOLISM (Great Britain) 24(5): 447-51, . 1989. 24(5). 447-51 .

104. Greenblatt, Janet. "Gamma Hydroxy Buterate (GHB) Abuse in the United States". Substance Abuse and Mental Health Services Administration Office of Applied Studies Working Paper, September The paper cites data from the 1996 Drug Abuse Warning Network report . 1997.

105. Kleinschmidt S. Bauer M. Grundmann U. Schneider A. Wagner B.. "Effect of gamma-hydroxybutyric acid and pentoxifylline on kidney function parameters in coronary surgery interventions. [German]". Anaesthesiologie und Reanimation. 1997. 22(4). 102

106. Rosen M I. Pearsall H R. Woods S W. Kosten T R. "The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal". Neuropsychopharmacology. 1996. 14(3). 187-193 .

107. Kleimenova NN, Ostrovskaya RU and Arefolov VA . "Effect of sodium hydroxybutyrate on the ultrastructure of the cross-striated muscle tissue myocytes during physical exercise". BYULL EKSP BIOL MED 88(9): 358-61, . 1979. 88(9). 358-61.

108. Ostrovskaya RU, Kleimenova NN, Kamisheva V, Molodavkin GM, Yavorskii AN and Boikko SS . "Effect of sodium hydroxybutyrate on functional biochemical and morphological indexes of physical working ability". FARMAKOL REGUL PROTSESSOV UTOMLENIYA [Moscow, USSR] . 1982. 39-56. 112-17.

109. Ferrara SD. Tedeschi L. Frison G. Rossi A. "Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication". Journal of Forensic Sciences. 1995. 40(3). 501-4

110. multiple authors. "The Lycaeum - GHB". http://www.lycaeum.org/drugs/synthetics/ghb.

111. multiple authors. "The Vaults of Erowid". http://www.erowid.org/entheogens/ghb.

112. Slater, Paul. "Re: legal status of GHB in the UK". altg.drugs. 4/1998. http://www.dejanews.com/.

113. Troll. "Re: Hillary Farias". misc.fitness.weights. 3/1998. http://www.dejanews.com/.

114. Baker, Joshua. "Re: GHB in australia". rec.drugs.chemistry. 3/1998. http://www.dejanews.com/.

115. Russell, Ken. "Re: GHB in australia". rec.drugs.chemistry. 3/1998. http://www.dejanews.com/.

116. Godbout, Roger; Jelenic, Patricia; Labrie, Christian; Schmitt, Martine; Bourguignon, Jean-Jacques. "Effect of gamma- hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat". Brain Research. 1995. 673(1). 157-6..

117. Snead, O. Carter, III. "The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures". Brain Research. 1994. 659(1-2). 147-56..

118. Xie, Xinmin; Smart, Trevor G. "gamma.-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices". Eur. Journal of Pharmacology. 1992. 223(2-3). 193-6..

119. Snead, O. Carter, III. "Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. European Journal of Pharmacology. 1992. 213(3). 343-9..

120. Xie, Xinmin; Smart, Trevor G. "gamma-Hydroxybutyrate hyperpolarizes hippocampal neurons by activating GABAB receptors". European Journal of Pharmacology. 1992. 212(2-3). 291-4..

121. Urban, Paul Francis; Frauli, Martine. "Effect of gamma-hydroxybutyrate on the electroretinogram of frog retina". Biochemical Socoety Transaction. 1983. 11(2). 214-15.

122. Snead, O. Carter, III. "Noradrenergic mechanisms in gamma-hydroxybutyrate-induced seizure activity". European Journal of Pharmacology 1987. 136(1). 103-8.

123. Maitre, Michel; Rumigny, Jean Francois; Cash, Christopher; Mandel, Paul. "Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain: principal localization in the synaptosomal fraction". Biochem. Biophys. Research Commun.. 1983. 110(1). 262-5.

124. Menon, M. K.. "gamma.-Hydroxybutyrate in experimental myoclonus". Neurology. 1982. 32(4Pt. 1). 434-7.

125. Rumigny, J. F.; Maitre, M.; Cash, C.; Mandel, P.. "Specific and non-specific succinic semialdehyde reductases from rat brain: isolation and properties". FEBS Letters. 1980. 117(1). 111-16..

126. Roth, Robert H.; Doherty, John D.; Walters, Judith R . "Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons?". Brain Research. 1980. 189(2). 556-60.

127. Doherty, John D.; Hattox, Susan E.; Snead, O. Carter; Roth, Robert H.. "Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain". Journal of Pharmacology and Experimental Therapy. 1978. 207(1). 130-9.

128. Cheramy, Andrea; Nieoullon, A.; Glowinski, J.. "Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat". Journal of Pharmacology and Experimental Therapy. 1977. 203(2). 283-93.

129. Godschalk, Moshe; Dzoljic, Mihailo R.; Bonta, Ivan L. "Slow wave sleep and a state resembling absence epilepsy induced in the rat by gamma-hydroxybutyrate". Eur. Journal of Pharmacology. 1977. 44(2). 105-11.

130. Benton, David; Kyriacou, Charalambos P.; Rick, John T.; Taberner, Peter V.. "Behavioral interactions between imidazoleacetic acid and gamma-hydroxybutyric acid in rats and mice". European Journal of Pharmacology. 1974. 27(3). 288-93.

131. Doherty, John D.; Snead, O. Carter; Roth, Robert H. . "Sensitive method for quantitation of gamma-hydroxybutyric acid and gamma-butyrolactone in brain by electron capture gas chromatography". Anal. Biochem.. 1975. 69(1). 268-77.

132. McCabe, Edward R. B. III. "Metabolic considerations in othe pharmacological interactions of gamma-hydroxybutyrate and related compounds with ethanol and ethanol oxidation". Dissertation; Availability: Avail. Univ. Microfilms Ann Arbor Mich. Order No. 72-27679.

133. Osuide, Gabriel. "Effects of gamma-hydroxybutyrate on chick behavior, electrocortical activity, and crossed extensor reflexes". British Journal of Pharmacology. 1972. 44(4). 593-604.

134. Marcus, Robert J. "Neuropharmacological studies of gamma-hydroxybutyrate and subsitiuted short chain aliphatic and cyclic compounds inducing epileptoid actions". Dissertation Availability: Avail. 70-5696

135. Aghajanian, George K.; Roth, Robert H.. "gamma.-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy". Journal of Pharmacology and Experimental Therapy. 1970. 175(1). 131-8.

136. Frank, George B.; Jhamandas, Khem H. "Effects of general depressant drugss on the electrical responses of isolated slabs of cat's cerebral cortex". British Journal of Pharmacology. 1970. 39(4). 707-15.

137. Frank, George B.; Jhamandas, Khem H. "Effects of drugs acting alone and in combination on the motor activity of intact mice". Britsih Journal of Pharmacology. 1970. 39(4). 696-706.

138. Oyama, Tsutomu; Kuko, Tsuyoshi; Shibata, Susumu; Matsumoto, Fumio. "Effects of gamma-hydroxybutyrate on plasma hydrocortisone concentration in man ". Anesth. Analg. (N. Y.). 1968. 47(4). 350-4.

139. Fishbein, William N. "Enzymic reactions involving gamma-hydroxybutyrate and gamma-butyrolactone". Dissertation Availability: Avail. 66-9284.

140. Fieler, Erin; Coleman, Daniel; Baselt, Randall. "Gamma-hydroxybutyrate concentrations in pre- and postmortem blood and urine". Clinical Chemistry. 1998. 44(3). 692.

141. MacMillian, V.. "The effects of Gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain". Brain Research. 1978. 146(1). 177-187.

142. Ames, Jeff. "Odorless, tasteless date rape drugs cause concern in the U.S.". CWRU Observer. 11/07/1997. http://www.cwru.edu/orgs/observer/110797/news4.htm. .

143. CNW. "Study sheds light on drug-related rape". http://www.newswire.ca/releases/February1998/12/c2961.html. 02/13/1998.

144. Maitre, Michel; Hechler, Viviane; Vayer, Philippe; et al.. "A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties". Journal of pharmacology and experimental theraputics. 1990. 255(2). 657-663.

145. Walters, Judith; Roth, Robert; Aghajanian, George. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. Journal of pharmacology and experimental theraputics. 1973. 186(3). 630-639.

146. Bustos; Roth, R.H.. Effect of Gamma-hydroxybutyrate on the release of monoamines from the rat striatum. British journal of pharmacology. 1972. 44(4). 817-820.

147. Handforth, Adrian; Sourkes, Theodore. Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment. European Journal of Pharmacology. 1975. 34. 311-319.

148. Spectrum quality products, Inc.. Bulk chemical prices. http://www.spectrumchemical.com. 1998

149. Pelchat. Personal Communication. pelchat_labs@bitsmart.com. 4/1998

150. Psychotherapeutic Drugs. 1340-1375. Bibliographic information missing.

151. Dean, Ward; Morgenthaler, Joy; Fowkes, Steven. GHB: The Natural Mood Enhancer. 1998. Smart Publications, Petaluma CA

152. MSDS (material safety data sheet) information. http://msds.lib.utexas.edu/n2c?urn:utlol:msds.mdl.OHS03684. Last Updated 4/27/1998

153. Food Nutrition Board of the National Academy of Sciences. Food Chemicals Codex, fourth edition. 1996. National Academy of Sciences press, Washington DC.

154. Sittig, Marshall. Handbook of Toxic and Hazardous Chemicals and Carcinogens, second edition. 1985. Noyes Publications, Park Ridge, NJ.

155. Ash, Irene; Ash, Michael. Handbook of Food Additives. 1995. Gower publications, Brookfield, VT.

156. McKin, William. Drugs and Behavior. 1997. Prentice Hall, Upper Saddle River, NJ.

Republicado: 06/Agosto/2007 - 17:18

1. Introdução.
2. Relatórios científicos sobre GHB.
3. Por que GHB foi proibido?
4. Quais são os interesses reais?
5. Efeitos.
6. Ação do GHB no corpo.
7. GHB e sonoSono é um estado ordinário de consciência, complementar ao da vigília (ou estado desperto), em que há repouso normal e periódico, caracterizado, tanto no ser humano como nos outros animais superiores, pela suspensão temporária da atividade perceptivo-sensorial e motora voluntária..
8. GHB, álcoolNa terminologia química, os álcoois constituem um nume­roso grupo de compostos orgânicos derivados de hidrocarbonetos que contém um ou mais grupos hidroxila (-OH). O etanol (ou álcool etílico, C2H5OH) é um dos membros dessa classe de compostos, e é o principal ingrediente psicoativo das bebidas alcoólicas. Por extensão, o termo “álcool” também é usado para referir-se a bebidas alcoólicas.O etanol resulta da fermentação de açúcar produzida por lêvedos. Em condições normais, as bebidas produzidas por fermentação têm uma concentração de álcool que não ultrapassa 14%. Na produção de álcoois por destilação, ferve-se uma mistura fermentada e o etanol que se evapora é recolhido como um condensado quase puro. Além do seu uso para consumo humano, o etanol é também usado como combustível, como solvente e na manufatura química (veja álcool impróprio para o consumo humano).O álcool absoluto (etanol anidro) é o etanol contendo não mais do que 1% de água por massa. Nas estatísticas sobre produção ou consumo de álcool, o álcool absoluto refere-se ao conteúdo de álcool (como 100% de etanol) das bebidas alcoólicas.Do ponto de vista químico, o metanol (CH3OH), também conhecido como álcool metílico e álcool de madeira (ou de amido), é o mais simples dos álcoois. É usado como um solvente industrial e também como um adulterador para desnaturar o etanol e torná-lo impróprio para o consumo (bebidas metiladas). O metanol é altamente tóxico; dependendo da quantidade consu­mida, pode produzir turvação da visão, cegueira, coma e morte.Outros álcoois impróprios para o consumo, com efeitos poten­cialmente nocivos, são consumidos ocasionalmente, como, p.ex., o isopropanol (álcool isopropílico, freqüente em desinfetantes) e etilenoglicol (usado como anticongelante em automóveis).O álcool é um sedativo/hipnótico com efeitos semelhantes aos dos barbitúricos. Além dos efeitos sociais do uso, a intoxi­cação pelo álcool pode resultar em envenenamento e até morte; o uso excessivo e prolongado pode resultar em dependência ou numa ampla variedade de transtornos mentais orgânicos e físicos.Os transtornos mentais e de comportamento decorrentes do uso de álcool (F10) são classificados como transtornos decor­rentes do uso de substância psicoativa na CID-10 (F10-F19).Veja também:cardiopatia alcoólica; cirrose alcoólica; dano cerebral associado ao álcool; delirium; encefalopatia de Wernicke; escorbuto; fígado gorduroso alcólico; gastrite alcoólica; hepatite alcoólica; miopatia relacionada com álcool ou drogas; neuro­patia periférica; pancreatite alcoólica; pelagra; pseudo-síndrome de Cushing; síndrome amnésica induzida por álcool ou droga; síndrome de deficiência de tiamina; síndrome fetal alcoólica., e Alcoolismo.
9. Outros usos de GHB.
10. GHB e sexo.
11. Segurança no uso.
12. Contraindicações
13. Dosagem.
14. Notas.
15. Referências.